Indiva Ltd. (TSXV: NDVA) (OTCQX: NDVAF) has received approval from Health Canada to add 10,000 square feet of production space at its facility.

The company’s production facility, based in London, Ontario, includes a nearly completed extraction and manufacturing space, which will be able to process 70 tones of biomass annually and produce cannabis-infused edibles.

The expansion project calls for three new grow rooms and two additional processing rooms. The additional square footage will, subject to applicable regulatory approvals, be used to manufacture edibles, increase the company’s flower production capacity, and enable new growth in the production, manufacturing, processing and refinement arms of the business, the company said in a statement.

Indiva plans to begin populating its three new flower rooms immediately. The cannabis grown in this space is expected to be turned into flower, pre-rolls, oil and distillate. The two newly-licensed processing rooms are expected to be dedicated to the company’s pre-roll production and chocolate manufacturing operation.

In addition, the company plans to submit its evidence package to Health Canada for the final phase of its London facility by the end of October. Once licensed, this will provide an additional 10,000 square feet of processing space.

“The approval of this license amendment powers the next step in our journey; infusing our cannabis into gourmet chocolate as well as other derivative products. We stand committed to following Health Canada’s regulations and are proud to receive clearance to continue forward with our strategy to meet the expectations of our supply agreements with provincial wholesalers. We look forward to bringing our exceptional cannabis and cannabis-infused products to more Canadians,” Indiva President and CEO Niel Marotta stated.